共查询到20条相似文献,搜索用时 203 毫秒
1.
2.
二甲基甲酰胺对胶质瘤细胞基因蛋白水平表达的影响 总被引:1,自引:0,他引:1
目的:观察诱导分化剂二甲基甲酰胺(DMF)地胶质瘤细胞C6的增殖抑制作用,探讨作用机理中DMF对c-myc、p16基因蛋白水平表达的影响。方法:「^3H」-T掺入法测增殖抑制率;免疫组化SP法测C-myc、p16基因蛋白水平的表达。结果:应用二甲基甲酰胺后,胶质瘤细胞CPM值降低,DNA合成总量减少。C-myc基因胞浆阳性表达下降,p16基因胞浆阳性表达升高。结论:二甲基酰胺对胶质瘤细胞增殖存在剂量依赖性抑制,作用机理与降低了癌基因C-myc对C6细胞恶性增殖的转录调节作用、增强了抑制基因p16活性有关。 相似文献
3.
4.
中国人血管抑制素Endostatin基因的分子克隆与序列鉴定 总被引:4,自引:0,他引:4
目的:内抑素(Endostatin)是一种有效的血管生成抑制因子,分离、克隆和测定中国人的Endostatin基因,为进一步研究Endoctatin的功能奠定了基础。方法:从中国人胎肝组织中提取mRNA,用RT-PCR方法将Endostatin的cDNA扩增出,克隆到pGEM-T载体中,测定其DNA序列。结果:中国人的Endostatin cDNA序列被成功克隆,序列分析证实为 Endostatin基因。结论:中国人的Endostatin cDNA基因编码序列与国外文献报道的相应序列完全一致。 相似文献
5.
目的研究ras基因激活在肾癌发生中的意义。方法应用聚合酶链反应-单链构象多态性分析(PCR-SSCP)和免疫组织化学检测肾癌组织K-ras基因第12位密码子突变及其基因产物p21蛋白的表达水平。结果42例肾癌中6例K-ras基因第12位密码子点突变,19例p21蛋白阳性表达,正常肾组织和癌旁组织均阴性。p21表达与肿瘤分期和分级有关。p21阳性患者的手术后生存率明显低于p21阴性患者。结论肾癌K-ras基因第12位密码子点突变并不常见,p21表达可能成为肾癌恶性程度和预后评价的指标。 相似文献
6.
目的 探讨p15基因变异及其与脑胶质瘤的发生、恶性进展的关系。方法 利用PCR和PCR-bsed甲基化检测技术检测了56例脑胶质瘤中p15基因外显子1缺失及5’CPG岛甲基化情况。结果 43例高级别的脑胶质瘤中,14例发生了p15基因缺失(32.6%),而13例低级别的脑胶质瘤中无一例发生p15基因缺失,差异具有显著性(P〈0.05)。1例低级别的脑胶质瘤、3例高级别的脑胶质瘤发生了p15基因5’CPG岛甲基化。结论 p15基因异常可能参与脑胶质瘤的发生、恶性进展。基因纯合缺失是脑胶质瘤中p15基因失活的主要机制。 相似文献
7.
8.
本文探讨了人睾丸癌组织中C-myc蛋白及ras基因产物P21蛋白表达的临床意义。方法:应用C-myc和P21单克隆抗体,通过免疫组织化学方法检测5例正常睾丸组织和27例睾丸癌组织中ras癌基因产物p21物C-myc蛋白的表达状况。结果:5例正常睾丸组织中未发现p21和C-myc蛋白阳性表达。阳性表达的p21和C-myc蛋白分别定位于肿瘤的细胞膜上和细胞核内。 相似文献
9.
10.
目的探讨d-艹宁烯在化学诱发实验性肿瘤及人实体瘤的防治作用及其机制。方法采用Westernblotting方法观察了d-艹宁烯对胰腺癌细胞中与膜结合的p21ras蛋白表达和法尼基蛋白转移酶活性的抑制作用。同时,采用免疫组化法观察了d-艹宁烯对p21ras在细胞膜上定位的影响。并以Northernbloting方法检测d-艹宁烯对H-ras癌基因在人胰腺癌细胞系中的表达。结果d-艹宁烯对人胰腺癌细胞呈现的抑制作用,其机制可能与其抑制法尼基蛋白转移酶活性,从而降低p21H-ras蛋白的异戊二烯化修饰有关。d-艹宁烯可降低p21ras蛋白的膜结合,增加胞浆p21ras蛋白的积蓄。在经d-艹宁烯处理过的胰腺癌细胞加入抗p21ras抗体,采用免疫组化法也可观察到上述现象。结论法尼基蛋白转移酶的抑制和p21ras蛋白膜结合与p21ras定位的改变密切相关。p21ras法尼基化的抑制作用改变了它在细胞内的定位,从而影响其生物学活性,但尚未发现与H-ras癌基因表达的密切相关。 相似文献
11.
目的:研究腺病毒介导的鼠内皮抑素基因对胃癌的治疗作用.方法:利用病毒重组技术将内皮抑素克隆入增殖缺陷型腺病毒基因组中,观察体外转染表达后的生物学活性.通过建立荷人胃癌的裸鼠动物模型,分析基因转导后动物肿瘤细胞中内皮抑素的表达情况及对肿瘤的抑制作用.结果:构建了表达内皮抑素的重组腺病毒载体pCA13-mEndo;检测到内皮抑素在体外的mRNA水平和蛋白质水平均有表达;鸡胚绒毛尿囊膜实验表明其对血管生长起抑制作用;荷瘤裸鼠体内肿瘤生长抑制明显.结论:所构建的pCA13-mEndo重组腺病毒载体可有效表达具有生物学活性的内皮抑素,使得肿瘤内微血管生成减少,肿瘤细胞增殖减慢,为抗血管生成方法治疗实体瘤的临床应用奠定基础. 相似文献
12.
外源性RGS16基因稳定转染对胶质瘤C6细胞生长的影响 总被引:1,自引:1,他引:0
背景与目的:有研究表明野生型p53可以诱导RGS16表达,而RGS16可能与胶质瘤的发生有关。本研究旨在探讨RGS16基因转染对大鼠胶质瘤C6细胞生长的影响。方法:构建真核表达载体pIRES2-EGFP-RGS16,脂质体法转染C6细胞,经G418筛选后荧光显微镜观察细胞中增强型绿色荧光蛋白(enhancedgreenfluorscentprotein,EGFP)的表达,RT-PCR证实RGS16的mRNA表达,免疫细胞化学方法检测细胞中RGS16蛋白表达。最后利用流式细胞仪、生长曲线、平板克隆形成等方法研究RGS16基因对胶质瘤细胞周期、生长及增殖的影响。结果:成功构建了稳定表达RGS16和表达空载体的细胞系C6-RGS16、C6-GFP。C6-RGS16、C6-GFP和C6经流式细胞仪检测S期的细胞比例分别为28.5%、18.9%和14.3%(P<0.05);生长曲线表明C6-RGS16生长的速度明显快于C6-GFP及C6,但其平板克隆形成率分别为12%、25%和25%(P<0.05)。结论:RGS16促进C6细胞周期从G1期向S期过渡,加快细胞生长速度,但是并不促进细胞克隆形成。 相似文献
13.
IL-24基因对大鼠胶质瘤细胞生长状况的影响 总被引:4,自引:0,他引:4
目的 探讨IL 2 4基因对C6大鼠胶质瘤细胞生长状况的影响。方法 应用逆转录病毒载体 ,将IL 2 4基因导入C6细胞 ,经G4 18筛选后获得表达IL 2 4分子的阳性细胞克隆C6 /IL 2 4 ;用RT PCR方法检测目的基因表达 ;四甲基偶氮唑蓝 (MTT)法检测细胞体外增殖状况 ,流式细胞技术检测细胞的增殖活性 ,并制作荷瘤动物模型 ,观察C6 /IL 2 4和C6细胞的体内致瘤性。结果 RT PCR检测表明 ,外源IL 2 4基因于mRNA水平在C6 /IL 2 4细胞已获得稳定表达。C6 /IL 2 4细胞系的体外增殖性较亲代C6细胞明显下降 ,流式细胞术检测其细胞增殖指数 (PI)为 (2 9.71± 0 .89) %。 9只接种C6 /IL 2 4细胞的实验组大鼠中 ,6只颅内成瘤 ,肿瘤体积为 (14 .0 8± 9.81)mm3 ,明显小于接种C6细胞大鼠的肿瘤体积 (P <0 .0 5 )。结论 外源性IL 2 4基因可部分抑制胶质瘤细胞异常增殖的肿瘤特性。 相似文献
14.
CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues 总被引:14,自引:0,他引:14
Jungbluth AA Chen YT Busam KJ Coplan K Kolb D Iversen K Williamson B Van Landeghem FK Stockert E Old LJ 《International journal of cancer. Journal international du cancer》2002,97(6):839-845
Angiogenesis is a vital component of the development and progression of many human solid tumors. Glioblastoma multiforme is one of the most highly vascularised class of solid tumors. Thus, we have investigated the potential antitumourigenic activity of endostatin, an angiogenic inhibitor, in the rat C6 glioma model. We have engineered C6 cells that endogenously express mouse endostatin in order to assess the growth of C6 tumors in vivo when endostatin is constitutively expressed. Endostatin secreted by stably transfected C6 cells is biologically active as shown by its inhibition (26%) of bFGF-stimulated proliferation of BAECs in culture. The subcutaneous implantation of endostatin-C6 cells in athymic (nu/nu) mice resulted in a reduced tumor growth rate (90% inhibition) compared to control cell lines throughout the duration of our experiments. Tumor inhibition was associated with a 50% reduction in the number of vessels, which were also smaller in morphology. However, endostatin-C6 tumors were no more necrotic than control tumors. The implantation of endostatin-C6 cells into immunocompetent Wistar rat brains also resulted in reduced tumor volumes (71% inhibition) compared to controls. Tumor cells were sparsely localised along the injection tract but had not formed discrete tumors. Despite the inhibitory response mediated by endostatin on C6 growth, complete tumor inhibition or dormancy was not observed in either the athymic or immunocompetent tumor models. These findings demonstrate that the endogenous expression of endostatin by C6 glioma cells results in a reduced tumor growth rate in vivo that is associated with an inhibition of tumor angiogenesis. Our data suggest that endostatin should be developed as an adjuvant gene therapy for the effective treatment of gliomas. 相似文献
15.
RI基因真核表达载体的构建及其对C6胶质瘤细胞生长的影响 总被引:8,自引:0,他引:8
目的通过构建核糖核酸酶抑制因子(ribonuclease inhibitor, RI)基因的真核表达载体——pLNCX-ri, 并转染C6神经胶质瘤细胞,探讨RI抑制肿瘤生长的作用机制.方法用Nde I / Xho从已构建的pET-ri上切下1.4 kb的RI基因片段,再构建到pLNCX上,获得真核表达载体(pLNCX-ri),采用Lipofect AMINE辅助转染大鼠C6神经胶质瘤细胞,经G418筛选获得稳定转染的细胞克隆,用Western blotting 检测RI基因的表达水平.将转染阳性的C6神经胶质瘤细胞接种于大鼠皮下,观察肿瘤的生长情况.结果在转染的C6神经胶质瘤细胞中,RI基因的表达量明显高于未转染的C6神经胶质瘤细胞,转染阳性的C6神经胶质瘤细胞在大鼠体内的成瘤潜伏期23±5.7天(对照组14±3.5天),瘤组织重量转染组1.35±0.43g比对照组2.40±0.61g(P<0.01)明显下降,瘤组织的血管密度转染组27.2±4.31比对照组47±6.54(P<0.01)明显减少.结论RI基因的转染对肿瘤的生长有明显抑制作用,其作用机制可能是抑制肿瘤组织血管的形成. 相似文献
16.
脂质体介导的鼠内皮细胞抑制素基因治疗人肝癌的研究 总被引:3,自引:0,他引:3
目的:利用内皮细胞抑制素进行肿瘤抗血管基因治疗的尝试。方法:用RT-PCR从鼠地脏扩增出内皮细胞抑制素cDNA,经测序证实后,装入分泌表达载体pSEC-hygromycin,用DEAE-葡聚糖将其转染COS-7细胞,从mRNA水平及蛋白水平检测内皮细胞抑制素的表达,并观察分泌上肖是否具有特异性抑制bFGF刺激的内皮细胞增殖作用,并通过TDT介导的dUTP缺口末端标记法和琼脂糖电泳来探讨其作用机制。 相似文献
17.
The multiple drug resistance protein (MDR1) is frequently overexpressed in human glioma. The aim of this study is to clone
the MDR1 promoter from C6/ADR, construct the double suicide genes expressive vector controlled by MDR1 promoter, and explore
its targeted expression in C6/ADR cells. MDR1 promoter from C6/ADR genomic DNA, which was linked with T vector, was amplified by using Polymerase chain reaction (PCR).
After cut by NdeI and HindIII, MDR1 promoter was cloned into pcDNA3-TK (thymidine kinase) plasmid. The cytosine deaminase
(CD) gene from pcDNA3-CD-TK plasmid was directly cloned into the above vector to construct pcDNA3-MDR1-promoter-CD-TK vector.
Then this vector was transfected into C6 and C6/ADR cells respectively by liposome. After selection by G418, the tumor cell
lines were stably established. Then these cell lines were examined through PCR and RT-PCR to respectively detect the integration
and expression of TK and CD genes. The results showed the length and sequence of MDR1 promoter amplified by PCR were confirmed
by DNA sequencing. The pcDNA3-MDR1-promoter-CD-TK expression vectors were constructed successfully. PCR indicated the double
suicide genes were integrated into C6 and C6/ADR cells. RT-PCR reveled that CD and TK genes expressed in C6/ADR/CD-TK cells,
whereas not in C6/CD-TK cells. In conclusions, construction of expressive vector containing double suicide genes controlled
by MDR1 promoter with targeted expression in C6/ADR will provide a sound basis for targeted gene therapy for multidrug resistance
(MDR) glioma. 相似文献
18.
V806M突变型Axin基因真核表达载体的构建及其在神经胶质细胞瘤内的表达 总被引:1,自引:0,他引:1
目的构建V806M突变型Axin基因真核表达载体pIRES2-EGFP-MT-Axin(V806M),并稳定表达于大鼠神经胶质瘤细胞系C6。方法用分子克隆技术,构建真核表达载体pIRES2-EGFP-MT-Axin(V806M),经NheⅠ和SmaⅠ双酶切鉴定后,用脂质体法稳定转染神经胶质瘤细胞C6。结果构建了真核表达载体pIRES2-EGFP-MT-Axin(V806M),稳定转染后,经荧光显微镜和免疫细胞化学染色法检测,可见细胞内有EGFP及Axin的表达。结论成功构建真核表达载体pIRES2-EGFP-MT-Axin(V806M),并在神经胶质瘤细胞C6中表达,为研究此种突变体Axin是否影响细胞的生物学行为以及是否参与胶质瘤的发生发展奠定了实验基础。 相似文献
19.
目的 观察苯乙酸(PA)诱导分化胶质瘤细胞C6过程中,同源盒(Hox)基因表达的变化。方法 根据引物的不同,将已知的22种Hox基因分为P1、P2、P3三组。用逆转录PCR(RT-PCR)及图像分析法,分组检测应用PA前后Hox基因组在C6细胞中的表达。对应用PA前后表达显著不同的Hox基因组,检测其特异Hox基因的表达。结果 C6细胞中,P2组基因表达明显弱于P1、P3组。应用PA后,P2组基因及P2组中Hox B2基因表达显著增强(P<0.001)。PA在分化诱导胶质瘤过程中,对Hox基因mRNA水平的表达有明显上调作用。结论 PA抑制胶质瘤细胞增殖的作用机理与调节胶质瘤细胞转录过程有关。 相似文献
20.
Yang L Lin Z Lin J Weng S Huang Q Zhang P Fu J 《International journal of oncology》2011,38(2):465-471
Endostatin is an anti-angiogenic agent that blocks endothelial cell proliferation, tumor growth, and metastasis. Several lines of direct evidence show that gliomas express high levels of endostatin. However, the anti-angiogenic activity and cellular mechanisms of endostatin from tumor cells have not been completely elucidated. In this study, we established C6 glioblastoma (GBM) xenografts in nude mice by subcutaneously injecting glioma cell lines, C6-null cells, and stable transfected-C6 cells overexpressing mock vector (C6-mock) and endostatin (C6-endo). We found that overexpression of endostatin in C6-endo cells significantly suppressed the expression of VEGF in tumor cells in vivo as well as in vitro. Furthermore, the tumor growth derived from C6-endo cells was inhibited. Our data demonstrate that endostatin could play a direct role in inhibiting tumor cells, and suggest that enhancing endostatin expression in gliomas could be an effective treatment strategy. 相似文献